Adora

Adora's primary endpoint was disease free survival, which is just really when you're on the drug is the disease suppressed. So I would imagine an alk adjuvant will have a disease free survival advantage. The second reason you might have an overall survival advantage is the reality of doing trials on an international basis,. Right now, it's whether you actually get the awesome mertonib or not.